Last update 19 Sep 2024

Resveratrol/Curcumin

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Mechanism
BAX agonists(Apoptosis regulator BAX agonists), DYRK1B inhibitors(DYRK-1 beta protein kinase inhibitors)
Inactive Indication-
Inactive Organization-
Drug Highest PhasePhase 2
First Approval Date-
RegulationFast Track (US), Orphan Drug (US)

Structure

Molecular FormulaC14H12O3
InChIKeyLUKBXSAWLPMMSZ-OWOJBTEDSA-N
CAS Registry501-36-0
View All Structures (2)

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Protoporphyria, ErythropoieticPhase 2
US
10 May 2023
CellulitePhase 2
US
09 Jan 2023
Adiposis DolorosaPhase 2
US
03 Oct 2022
Subcutaneous fat disorderPhase 2
AU
03 Feb 2020
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
23
(ahuowudfja) = rnkrzdgesu rgqjgtowgu (dpylmdiadq, 1.3)
Met
Positive
25 Apr 2024
Phase 2
12
(gfsfrbascm) = zebrjtnaco pnzduehhno (eustwphmup, 0.9)
Met
Positive
25 Apr 2024
Phase 2
25
(CBL-514 320 mg)
bpkyweejfk(ichcqdnsrj) = orprsogzyq ifuxrtlpuz (dosnlyneee, rcrsogbwkf - hddhxipkrn)
-
28 Mar 2024
(CBL-514 480 mg)
bpkyweejfk(ichcqdnsrj) = dvdakwtfcx ifuxrtlpuz (dosnlyneee, qtuuwajupl - evmxfsgcfj)
Phase 2
76
(hfvujaeiqq) = aexohiichs lvtaclmmgo (vekxgluqcl )
Positive
26 Dec 2023
Placebo
-
Phase 2
76
atabxqnfoi(xbvwaccqfe) = uqokgxwkmh hrjaqmhleo (mypwdslpeu )
Met
Positive
02 Oct 2023
Placebo
atabxqnfoi(xbvwaccqfe) = dxlhvlcefg hrjaqmhleo (mypwdslpeu )
Met
Phase 2
12
prtjcafpdd(qwbsjdeugt) = in the high-dose group was reduced by 51.3% (p<0.0001) and 54.7% (p<0.0001) at 4 and 8 weeks after CBL-514 treatments, in the low-dose group was reduced by 40.0% (p=0.0002) and 34.7% (p<0.0001) at 4 and 8 weeks after CBL-514 treatments. izkwibbehi (apszbvsuyk )
Met
Positive
13 Sep 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free